Germany: Grunenthal issues €300m to take out Nebido acquisition loan Grunenthal, a pharmaceutical company headquartered in Aachen, has priced €300m (US$328m) of 6.75% senior secured notes due 2030. The Reg…
Germany: Grunenthal issues €300m to take out Nebido acquisition loan Grunenthal, a pharmaceutical company headquartered in Aachen, has priced €300m (US$328m) of 6.75% senior secured notes due 2030. The Reg…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference